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Abstract
Introduction: The objective of the study was the development of models of cognitive functions in a group of post-menopausal women, 
according to the concentration of the selected laboratory parameters evaluating the functional state of the thyroid gland.
Material and methods: The study was conducted during 2012–2014, and covered women aged 50–65 years, minimum two years after 
the last menstruation, without chronic diseases, cancerous diseases, mental disorders, addiction to drugs or alcohol, and who did not use 
hormone replacement therapy. At the stage of qualification, a brief MoCA test was performed; 383 women were qualified for the study.
Blood was collected for the determination of such parameters as: TSH, TT4, fT4, anti-TPO, anti-Tg, and AB-TSHR. Assessment of cognitive 
functions was performed using the diagnostic instrument Central Nervous System — Vital Signs (CNS-VS) (Polish version). The results 
were statistically analysed.
Results: The mean age of the women in the study was 56.4 ± 3.4; the mean TSH was 1.91 ± 1.35 mU/L, fT4 14.76 ± 2.34 pmol/L, and 
TT4 99.12 ± 16.98 nmol/L. Mean values were: 64.74 IU/L for anti-TPO, 100.69 IU/L for anti-Tg, and 1.40 IU/L for AB-TSHR. The examined 
women obtained the neurocognitive index (NCI) on the level of 84.4 scores, on average. The lowest results were obtained in tests assessing 
cognitive flexibility (mean 78.64 scores), processing speed (mean 79.25 scores), and executive functions (mean 79.75 scores). In the tests 
evaluating complex attention, the mean values were 82.24 scores, psychomotor speed — mean 83.42 scores, and reaction time — mean 
86.87 scores. The women examined obtained the best results in tests assessing memory (mean 90.15 scores), including verbal (mean 91.22 
scores), and visual (mean 93.37 scores).
The NCI and cognitive function models were assessed from the aspect of thyroid gland examinations in post-menopausal women. Based 
on the analyses performed, the following conclusions were drawn:
1. The developed models of cognitive functions indicate a considerable effect of TSH, fT4, AB-TSHR, and anti-TPO, as well as TT4 and 
anti-Tg, on the level of cognitive functions after menopause in the group examined.
2. The conducted study suggests the need for examination of the functional state of the thyroid gland in post-menopausal women who 
show cognitive function disorders. (Endokrynol Pol 2017; 68 (3): 290–298)
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Streszczenie
Wstęp: Celem pracy było opracowanie modeli funkcji poznawczych w grupie kobiet po menopauzie w zależności od stężenia wybranych 
parametrów laboratoryjnych oceniających stan funkcjonalny tarczycy.
Materiał i metody: Badanie przeprowadzono w latach 2012–2014. Zbadano kobiety w wieku 50–65 lat; minimum 2 lata od ostatniej mie-
siączki, bez chorób przewlekłych, chorób nowotworowych, chorób psychicznych,  uzależnień od leków i alkoholu oraz nieprzyjmujące 
hormonalnej terapii zastępczej. Na etapie kwalifikacji przeprowadzono krótki test MoCA. Do badania zakwalifikowano 383 kobiety.
Badanym pobrano krew do oznaczeń takich parametrów, jak: TSH, TT4, fT4, anty-TPO, anty-Tg, AB-TSHR. Ocenę funkcji poznawczych 
przeprowadzono na podstawie aparatury diagnostycznej funkcji poznawczych CNS-VS (wersja polska). Wyniki poddano analizie sta-
tystycznej.
Wyniki: Średnia wieku badanych kobiet wynosiła 56,4 ± 3,4 roku. Badane miały TSH średnio 1,91 ± 1,35 mU/l, fT4 14,76 ± 2,34 pmol/l 
i TT4 99,12 ± 16,98 nmol/l. Średnie wartości wynosiły 64,74 IU/l dla anty-TPO, 100,69 IU/l dla anty-Tg i 1,40 IU/l dla AB-TSHR. Badane kobiety 
uzyskały indeks neurokognitywny (NCI) średnio na poziomie 84,4 pkt. Najniższe wyniki uzyskały w testach oceniających plastyczność 
poznawczą (średnio 78,64 pkt.), szybkość przetwarzania (średnio 79,25 pkt.) i funkcje wykonawcze (średnio 79,75 pkt.). Wyniki w testach 
oceniających skupianie uwagi wynosiły średnio 82,24 pkt., szybkość psychomotoryczną — średnio 83,42 pkt. oraz czas reakcji — średnio 
86,87 pkt. Najlepsze wyniki osiągnęły badane kobiety w testach oceniających pamięć (średnio 90,15 pkt.), w tym werbalną (średnio 91,22 
pkt.) i wzrokową (średnio 93,37 pkt.).
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Wnioski: Oszacowano modele NCI i funkcji poznawczych względem badań tarczycowych u kobiet po menopauzie. Na podstawie prze-
prowadzonych analiz wyciągnięto wnioski:
1. Opracowane modele funkcji poznawczych wskazują na znaczny wpływ TSH, FT4, AB-TSHR i anty-TPO, jak również TT4 i anty-Tg 
na poziom funkcji poznawczych po menopauzie w badanej grupie.
2. Przeprowadzone badanie sugeruje potrzebę badania stanu funkcjonalnego tarczycy u kobiet po menopauzie wykazujących zaburzenia 
funkcji poznawczych.
(Endokrynol Pol 2017; 68 (3): 290–298)
Słowa kluczowe: funkcje poznawcze; tarczyca; menopauza
Introduction
In recent years, civilisation progress and tremendous 
advances in medicine have resulted in a considerable 
prolongation of the human life span. In developed 
countries, the mean life span of women exceeds 80 
years [1, 2]. Therefore, it is very important to recognise 
the mechanisms regulating the processes of ageing of 
the human body, which concern many systems and 
organs, including the endocrine system. Menopause in 
women is associated with the cessation of the reproduc-
tive ovarian function, and thus the loss of fertility and 
many somatic and mental disorders [3–6]. In Poland, the 
mean age at menopause is 51.25 years [7]. Despite the 
prolongation of life span, the mean age at menopause 
has not changed for many years. According to the data 
quoted, a woman lives one third of her lifetime after 
menopause. Thus, this is not a period of decline, but 
a subsequent stage in a woman’s life.
Hormonal changes taking place in woman’s body 
after menopause are responsible for the development 
of many disorders and complaints. During this period 
there develop in women psychological, somatic, and 
vasomotor symptoms of the menopausal syndrome; 
incontinence is more frequent, there occur changes in 
the connective tissue, as well as in the bone tissue, lead-
ing to the development of postmenopausal osteopaenia 
and osteoporosis. All these changes decrease the quality 
of life of women during this period [8, 9]. The fact of 
the deterioration of cognitive functions with age is well 
known [10]. In post-menopausal women, a decline was 
observed in the efficacy of cognitive functions, which 
fall below the average for the general population. It was 
confirmed that women obtained the worst results with 
respect to the speed of processing, cognitive plasticity, 
and executive functions, whereas the best results were 
with respect to verbal memory and visual memory [11]. 
The theory of these changes that is most frequently 
considered is a rapid decline in sex hormones after 
menopause, and in consequence, the deterioration of 
cognitive functions. This theory has been confirmed 
by many studies, which showed the neuroprotective 
role of oestrogens and androgens on the nerve cells 
[12–14]. Nevertheless, investigations of the effect of 
oestrogen supplementation on cognitive functions 
after menopause did not bring about an unequivocal 
confirmation of this theory [15–17].
Dysfunctions of the thyroid gland commonly occur 
in the general population, especially among women. 
The effect of thyroid hormones on metabolism, includ-
ing the metabolism of the brain, has been known for 
years; however, the effect of the thyroid hormones on 
the brain has not been fully explained. It was found that 
thyroid hormones exert an effect on brain metabolism, 
modulate gene expression, and affect the transmis-
sion of signals between cells, among others, by the 
synthesis of enzymes necessary for the production of 
neurotransmitters [18]. The effect of thyroid hormones 
in known on the neurotransmitter systems: noradre-
nergic, serotonergic, and GABA-ergic. The effect of 
thyroid hormones on the brain in adults probably takes 
place by the regulation of activity and synthesis of G 
proteins. The deficiency of thyroid hormones impairs 
the transmission of signals via adenylyl cyclase and 
phosphoinositide [19]. According to the most recent 
hypothesis, thyroid hormones regulate brain functions 
mainly through the effect on the catecholaminergic 
system [20].
The scope of problems concerning cognitive func-
tion disorders in thyroid function disorders has been 
considerably more poorly recognised and at present 
is the subject of many studies. Studies concerning the 
relationship between menopause and thyroid function 
are scarce and do not explain whether menopause has 
an effect on the thyroid gland, irrespective of ageing, or 
whether the changes taking place in the thyroid gland 
with age affect the course of natural menopause. The 
major changes in the area of physiology and function 
of the thyroid gland related with the ageing process 
are: decrease in the uptake of iodine in the thyroid 
gland, decrease in the synthesis of free thyroxine and 
triiodothyronine, an increase in free thyroxine catabo-
lism, and an increase in reverse triiodothyronine. Most 
often, the TSH level remains normal; however, with 
time it shows a tendency towards the upper limit. The 
researchers report that menopause may modify clinical 
expression of some thyroid gland diseases, especially 
autoimmune [21].
The objective of the study was development of 
the models of cognitive functions in a group of post-
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menopausal women, according to the concentration 
of the selected laboratory parameters evaluating the 
functional state of the thyroid gland.
Material and methods
The study group were women from the south-eastern 
areas of Poland. The study was conducted during 
2012–2014. The criteria for enrolment into the study 
were: age 50–65 years; education at least completed 
primary, and a minimum of two years after the last 
period. The criteria of exclusion from the study were as 
follows: chronic diseases within the last five years be-
fore recruitment, including a diagnosed thyroid gland 
disease; an active cancerous disease within the last five 
years before recruitment; mental disease in medical 
history; addiction to drugs and alcohol; and a disease 
unit with dementia symptoms diagnosed.
At the stage of qualification to the study, a brief 
MoCA test was performed in order to include into the 
study the women who do not show the features of de-
mentia. The maximum number of scores in this test is 
30, and the result of 26 or more scores is considered as 
normal. All the examined women who were included 
into the further stages of the study obtained more than 
26 scores in the MoCA test [22].
Blood was collected from the examined women for 
the determination of such parameters as: thyroid-stim-
ulating hormone, total thyroxine (TT4), free thyroxine 
(fT4), anti-thyroid peroxidase antibodies (anti-TPO), 
anti-thyroid peroxidase antibodies (anti-Tg), and TSH 
receptor antibodies (AB-TSHR). The blood samples 
were immediately delivered to the laboratory. The 
determinations were performed in an accredited SY-
NEVO Laboratory.
Cognitive functions were assessed by means of the 
diagnostic instrument for the assessment of cognitive 
functions — Central Nervous System — Vital Signs 
(CNS-VS) (Polish version), using the CNS Vital Signs, 
1829 East Franklin Street, Bldg 500, Chapel Hill, NC 
27514, 919-933-0932 software. The instrument, in the 
form of a battery of computer tests, was subjected to the 
full validation procedure. The validation procedure on 
a computer was performed in Polish [23]. The tests were 
performed under the supervision of a psychologist.
The presented cognitive functions were evaluated 
as the following domains: memory, verbal memory, 
visual memory, processing speed, executive functions, 
psychomotor speed, reaction time, complex attention, 
and cognitive flexibility.
Mean standardised results obtained from the tests 
were used for the calculations. The clinical report from 
the CNS Vital Signs test classifies the examined women 
into five groups, according to the Neurocognitive In-
dex (NCI), and nine cognitive functions. Standardised 
results are calculated in a way to classify the examined 
women into intervals described as: 5 — above aver-
age (> 109), 4 — average (90–109), 3 — below average 
(80–89), 2 — low (70–79), 1 — very low (< 70).
The report from the CNS VS test provides the value 
of the Neurocognitive Index, which is computer cal-
culated in an integrated way, based on five domains: 
memory, psychomotor speed, reaction time, complex 
attention, and cognitive flexibility.
The collected data were statistically analysed using 
the statistical software package STATISTICA. Tables pre-
sented the minimum and maximum values, arithmetic 
mean (M), and standard deviations (SD), absolute num-
ber (n), and relative number (ratio between the number 
of units of a given feature variant to the number of the 
sample expressed in %).
Ten NCI regression models and cognitive functions 
were assessed with respect to the characteristics of the 
thyroid gland in the women examined. The explained 
variable was first the Neurocognitive Index and then the 
subsequent cognitive functions (standard scores). The 
explanatory variables were characteristic of the thyroid 
gland. The selection of the explanatory variables to the 
models were performed by the method of step-wise re-
gression forward until the moment when all the explana-
tory variables in the models were statistically significant. 
As a measure of the quality of regression models, the 
coefficient of multiple correlation was adopted, and the 
coefficient of determination, which is its square. In sta-
tistical tests the level of significance was set at α = 0.05.
The study covered 383 postmenopausal women, 
aged 50–65 years; mean age 56.4 ± 3.4 years.
The study obtained approval from the Bioethics 
Committee at the Institute of Rural Health in Lublin.
Results
The functional state of the thyroid gland in the exam-
ined women was assessed based on the concentration 
of: TSH, fT4, TT4, and anti-thyroid antibodies (anti-TPO, 
anti-Tg, and AB-TSHR). The women in the study had 
a mean TSH level of 1.91 ± 1.35 mU/L, fT4 mean 14.76 
± 2.34 pmol/L, and TT4 mean 99.12 ± 16.98 nmol/L. 
The mean concentrations of anti-thyroid antibodies 
were 64.74 IU/L for anti-TPO, 100.69 IU/L for anti-Tg, 
and 1.40 IU/L for AB-TSHR (Table I).
The women in the study obtained the Neurocog-
nitive Index on the level of 84.4 scores, on average, 
showing a general assessment of cognitive functions on 
a level lower than the general average. The examined 
women obtained the worst results in tests evaluating 
cognitive flexibility (mean 78.64 scores), processing 
speed (mean 79.25 scores), and executive functions 
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(mean 79.75 scores), which indicated low evaluations 
of these cognitive functions. Slightly better results were 
obtained in tests assessing complex attention (mean 
82.24 scores) and psychomotor speed (mean 83.42 
scores), and even better with respect to the reaction 
time (mean 86.87 scores), showing the evaluations of 
these cognitive functions below average. The exam-
ined women obtained the best results in tests assessing 
memory (mean 90.15 scores), including verbal memory 
(mean 91.22 scores) and visual memory (mean 93.37 
scores), which indicated the average evaluations of 
these cognitive functions (Table II).
Table III shows the result of assessments of the NCI 
models and cognitive functions (scores) with respect to 
the parameter examined. The coefficients of multiple cor-
relation, and consequently the coefficients of determina-
tion for all models, are statistically significant (p ≤ 0.05).
Figure 1 illustrates the significant effect of the exam-
ined thyroid gland parameters on NCI and cognitive 
functions of postmenopausal women.
For the models of the Neurocognitive Index, execu-
tive functions, and cognitive flexibility, a similar set of 
thyroid gland parameters was obtained (TSH, TT4, and 
AB-TSHR), the effect of which on those functions was 
significantly negative.
The Neurocognitive Index was lower by 0.14 scores, 
on average, if the TSH level was higher by 0.1 mU/L; 
0.09 scores if the concentration of TT4 was higher by 
nmol/L; and 0.42 scores if the level of AB-TSHR was 
higher by 0.1 IU/L.
The results for cognitive functions were lower, on 
average, by 0.30 scores if the TSH level was higher by 
0.1 mU/L; 0.18 scores if the concentration of TT4 was 
higher buy 1 nmol/L; and 0.66 scores if the level of AB-
TSHR was higher by 0.1 IU/L.
The results concerning cognitive flexibility were 
lower, on average, by 0.28 scores if the level of TSH was 
higher by 0.1 mU/L; 0.18 scores if the concentration of 
TT4 was higher by 1 nmol/L; and 0.67 scores of the level 
of AB-TSHR was higher by 0.1 IU/L.
Table II. Cognitive functions (standardised results) of the examined women
Tabela II. Funkcje poznawcze (wyniki standaryzowane) badanych kobiet
Cognitive functions Min–Max M ± SD Evaluations
Very low Low Low average Average Above
Standard scores % % % % %
NCI 29–115 84.41 ± 16.24 16.97 20.10 15.14 46.48 1.31
Memory 44–128 90.15 ± 15.65 8.36 18.02 24.28 32.38 16.97
Verbal memory 42–125 91.22 ± 17.75 9.92 14.62 16.71 38.64 20.10
Visual memory 47–125 93.37 ± 15.03 5.74 10.44 25.07 46.74 12.01
Processing speed 26–117 79.25 ± 14.35 22.19 26.37 24.02 25.85 1.57
Executive functions 18–124 79.75 ± 25.08 29.50 11.75 16.45 32.11 10.18
Psychomotor speed 22–116 83.42 ± 18.07 18.28 14.36 24.28 37.60 5.48
Reaction time 36–121 86.87 ± 16.72 11.49 16.97 26.37 40.47 4.70
Complex attention 6–121 82.24 ± 28.64 24.02 12.53 12.79 37.08 13.58
Cognitive flexibility 18–125 78.64 ± 26.08 26.37 15.40 16.71 31.85 9.66
Table I. Selected parameters of the functional status of the thyroid gland in the examined women
Tabela I. Wybrane parametry stanu funkcjonalnego tarczycy u badanych kobiet
Characteristics of 
thyroid gland
Unit Min–Max M ± SD Below normal Normal Above normal
% % %
TSH mU/L 0.27–7.36 1.91 ± 1.35 0.00 91.91 8.09
fT4 pmol/L 9.32–22.16 14.76 ± 2.34 11.23 88.25 0.52
TT4 nmol/L 62.99–146.70 99.12 ± 16.98 1.57 98.43 0.00
Anti-TPO IU/L 5.00–600.00 64.74 ± 125.04 0.00 75.46 24.54
Anti-Tg IU/L 8.00–800.20 100.69 ± 161.56 0.00 76.24 23.76
AB-TSHR IU/L 0.31–3.80 1.40 ± 0.56 0.00 60.31 39.69
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Figure 1. Changes in the results for cognitive functions (scores) conditioned by an increase in thyroid gland characteristics in the 
examined women
Rycina 1. Zmiany wyników funkcji poznawczych (pkt.) warunkowane wzrostem charakterystyk tarczycy u badanych kobiet
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Table III. Assessment of cognitive function models with respect to the functional state of the thyroid gland in the examined 
women
Tabela III. Oszacowania modeli funkcji poznawczych względem stanu funkcjonalnego tarczycy u badanych kobiet
Cognitive function Parameter Assessment Standard 
deviation
t p R F p
NCI Intercept 101.92 5.29 19.284 < 0.001
0.216 6.212 < 0.001
AB-TSHR [IU/L] –4.21 1.48 –2.849 0.005
TSH [mU/L] –1.39 0.61 –2.284 0.023
TT4 [nmol/L] –0.09 0.05 –1.815 0.070
Memory Intercept 103.20 4.70 21.974 < 0.001
0.194 7.428 < 0.001Anti TPO [IU/L] –0.02 0.01 –2.950 0.003
TT4 [nmol/L] –0.12 0.05 –2.577 0.010
Verbal memory Intercept 106.01 5.29 20.021 < 0.001
0.222 9.843 < 0.001TT4 [nmol/L] –0.13 0.05 –2.520 0.012
Anti TPO [IU/L] –0.03 0.01 –3.733 < 0.001
Executive functions Intercept 112.08 8.09 13.858 < 0.001
0.253 8.665 < 0.001
AB-TSHR [IU/L] –6.57 2.26 –2.907 0.004
TSH [mU/L] –2.98 0.93 –3.188 0.002
TT4 [nmol/L] –0.18 0.08 –2.309 0.021
Psychomotor speed Intercept 71.04 5.93 11.970 < 0.001
0.162 5.100 0.007fT4 [pmol/L] 0.90 0.39 2.299 0.022
Anti TPO [IU/L] –0.01 0.01 –1.990 0.047
Reaction time Intercept 85.59 1.00 85.510 0.000
0.123 5.862 0.016
Anti TG [IU/L] 0.01 0.01 2.421 0.016
Complex attention Intercept 87.72 2.51 34.910 < 0.001
0.136 7.152 0.008
TSH [mU/L] –2.87 1.07 –2.674 0.008
Cognitive flexibility Intercept 110.92 8.44 13.139 < 0.001
0.240 7.710 < 0.001
AB-TSHR [IU/L] –6.68 2.36 –2.832 0.005
TSH [mU/L] –2.77 0.98 –2.835 0.005
TT4 [nmol/L] –0.18 0.08 –2.238 0.026
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A similar set of thyroid gland characteristics was 
obtained for the models of memory and verbal memory 
(TT4 and anti-TPO), the effect of which on these func-
tions was significantly negative.
The results for memory were lower, on average, 
by 0.12 scores if the concentration of TT4 was higher 
by 1 nmol/L; and 0.19 scores if the concentration of 
anti-TPO was higher by 10 IU/L. The results for verbal 
memory were lower on average by 0.13 scores if the 
concentration of TT4 was higher by 1 nmol/L; and 0.27 
scores if the concentration of anti-TPO was higher by 
10 IU/L.
For the models of psychomotor speed, reaction 
time, and complex attention, various sets of thyroid 
gland characteristics were obtained, which exerted 
a significant effect on these functions.
The results of psychomotor speed were higher, on 
average, by 0.90 scores if the concentration of fT4 was 
higher by 1 pmol/L; and lower, on average, by 0.15 
scores when the concentration of anti-TPO was higher 
by 10 IU/L. 
The results concerning the reaction time were 
higher, on average, by 0.13 scores if the concentration 
of anti-Tg was higher by 10 IU/L.
The results for complex attention were lower, on 
average, by 0.28 scores if the TSH level was higher by 
0.1 mU/L.
Discussion
Observations encouraging the search for causes of 
cognitive disorders in the group of women after meno-
pause result from the fact that Alzheimer’s disease 
more often afflicts females than males [24–26]. Usually, 
an acceleration of its development is observed in post-
menopausal women.
Results of the CNS VS tests in our own studies 
of postmenopausal women allowed characterisation 
of NCI and cognitive functions of the women in the 
study. They obtained worse results with respect to NCI, 
memory, cognitive flexibility, executive functions, reac-
tion time, psychomotor speed, and processing speed. 
In these domains, more than a half of the women ob-
tained evaluations below average, poor, or very poor. 
Definitely the greatest disorders occurred with respect 
to the processing speed, where more than 70% of the 
women obtained results below average. The highest 
percentage of very poor evaluations was obtained 
by the women in the study with respect to executive 
functions, cognitive flexibility, complex attention, and 
processing speed. The least disorders were found in 
the tests assessing verbal memory and visual memory. 
In the WHIMS study conducted among slightly older 
women, aged over 65 years, the cognitive deficit in at 
least one domain was present in 82.1% of the study 
participants, and in the majority of them (74.3%) deficits 
occurred in many cognitive domains [27]. The results 
obtained in our own study and the WHIMS reports 
confirm that postmenopausal women may be a group 
burdened with an especially high risk of the develop-
ment of dementia. Researchers from California Univer-
sity confirmed that the processing speed of information 
declines in the early and late perimenopausal period; 
however, according to these researchers verbal memory 
also deteriorates [28].
Despite the fact that the thyroid function plays its 
role in cognition, the relationship between the state 
of the thyroid gland and neuropsychiatric symptoms 
still remains unclear in individuals without clinical 
symptoms of thyroid disorders or laboratory results in 
euthyreosis. In our own study, an attempt was under-
taken to investigate the relationship between various 
parameters of thyroid gland functioning and cognitive 
functions in postmenopausal women without clinical 
symptoms of thyroid gland diseases. The considerations 
covered not only TSH and thyroid hormones (TT4 and 
fT4), but also anti-thyroid antibodies (anti-TPO, anti-Tg, 
and AB-TSHR). In the results of the study, the high per-
centage of women with elevated AB-TSHR values and 
lack of other indicators of thyroid function disorders 
deserves attention. Possibly, the values slightly above 
the normal value (maximum concentration 3.8 IU/L) 
do not exert any significant effect on the thyroid func-
tion, and this is a transient state. The limitation of the 
presented study is the lack of follow-up examinations 
after the specified period of time.
It was found that in the developed models the 
results for NCI, executive functions, and cognitive flex-
ibility decreased if the concentration of TSH, TT4, and 
AB-TSHR increased. The greatest deterioration effect 
on the above-mentioned functions was exerted by the 
concentration of AB-TSHR. The results for complex at-
tention in the examined postmenopausal women were 
lower if the level of TSH was higher. In the model of 
memory and verbal memory the results were lower if 
the concentration of TT4 and anti-TPO increased. An 
increase in the concentration of anti-TPO exerted the 
greatest effect on the deterioration of memory. In the 
model for psychomotor speed, the examined women 
obtained higher results with an increase in fT4, and 
lower results with an increase in anti-TPO. In the reac-
tion time model, the results were higher, together with 
an increase in anti-Tg.
The studies conducted by Italian researchers among 
337 older people without clinical thyroid gland disorders, 
who were assessed with respect to cognitive functions 
using the tests: Mini Mental State Examination (MMSE), 
Prose Memory Test (PMT), and Matrix Test (MT), a nega-
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tive correlation was found between TSH and results for 
MMSE, PMT, and MT, which is in accordance with the 
results of our own study. However, no relationship was 
observed between the levels of fT4 and the results of 
the tests: MMSE, PMT, and MT [29]. Nevertheless, these 
results cannot be directly referred to our own studies 
because the mean age of the population examined was 
74.3, i.e. 20 years more than in our own material.
Based on the data obtained in the study Healthy 
Aging in Neighbourhoods of Diversity Across the 
Life Span (HANDLS) study cognitive functions were 
assessed using 13 cognitive functions tests, which 
covered, among others, such examined domains as: 
learning, memory, verbal memory, visual memory, 
psychomotor speed, executive functions. It was con-
firmed that an elevated concentration of fT4 correlated 
with better results in the tests of spatial perception in 
the whole group examined, as well as among females 
and Afro-Americans. A higher concentration of fT4 
positively correlated with perception abilities and 
memory in the group of women and Afro-Americans. 
Higher concentrations of TT4 correlated with better 
results with respect to psychomotor speed, whereas 
higher levels of hormones fT4 and TT4 correlated with 
better results in verbal tests in the group of males. 
The levels of TSH below the reference values cor-
related with better psychomotor speed and complex 
attention tests [30]. The results of this study confirm 
the results obtained in our own study in a group of 
women where the TSH values negatively correlated 
with the results obtained for executive functions, 
complex attention, and cognitive flexibility, whereas 
the level of fT4 positively correlated with the results 
for psychomotor speed. The relationship between 
TT4 and lower results of cognitive functions may 
result from the effect of thyroid hormone binding 
proteins. This requires further explanation in scientific 
studies.
Similar results with respect to TSH were obtained 
by Hogervorst et al. in a study that covered a group of 
1047 people; mean age 64 years. During two years of 
observation, he discovered that high levels of TSH posi-
tively correlated with worse results in the MMSE test. 
This researcher obtained different results with respect 
to fT4, finding that high normal concentrations of fT4 
positively correlated with worse results in the MMSE, 
and deterioration of the test results by at least 4 scores 
within two years of observation [31]. Choi et al. also 
noted that a higher concentration of fT4 in individuals 
with euthyreosis was related with worse results for 
executive functions [32].
Results similar to own studies were obtained 
by Gunnarsson et al., where a decrease in memory 
negatively correlated with the concentrations of TT4 
in serum, and positively with the levels of TSH in 
serum [33]. Also, studies by Boxtel et al. conducted in 
a group of 120 individuals aged 49–71 years confirm 
the above-mentioned results. They observed a negative 
correlation between the level of TSH and memory [34].
Other results were presented by the authors of 
a meta-analysis of 23 studies, who evaluated the re-
lationship between low levels of TSH and cognitive 
functions. Based on 14 correctly designed and cor-
rectly conducted studies, they showed a relationship 
between sub-clinical hyperthyroidism and cognitive 
function disorders or dementia [35]. Other researchers 
also found that in the elderly without dementia, low 
TSH was related with the deterioration of cognitive 
functions [36, 37].
Nevertheless, the report from the study of a group 
of 5154 males and females aged 70–82 years, without an 
earlier diagnosis of thyroid function disorders, where 
the cognitive functions were tested using five neu-
ropsychological tests — in the beginning of the study 
and after subsequent time points during observation 
lasting for three years — did not report any differences 
between the result of cognitive tests in sub-clinical 
hyperthyroidism and hypothyroidism with respect to 
the results of cognitive tests among study participants 
with euthyreosis [38]. Similar results were presented 
by Ojala et al. [39].
In our own study conducted among postmenopau-
sal women, the relationship was also analysed between 
the level of anti-thyroid antibodies and cognitive func-
tion disorders. On the one hand, this is important be-
cause, according to literature, at the age of over 60 years 
the susceptibility to autoimmune diseases is higher [40], 
including autoimmune thyroid gland diseases, which 
actually constitute the main cause of hypothyroidism; 
and on the other hand, menopausal transition may 
also modify the clinical expression of selected thyroid 
gland diseases, especially autoimmune [21]. In our own 
studies of women after menopause but not older than 
65 years, a high percentage of anti-thyroid antibodies 
was also found. Similar data are reported by Resta et 
al. [41]. They found that older women, irrespective of 
age, are more often afflicted by thyroid gland disease 
than males. They also confirmed that the frequency 
of occurrence of autoimmune thyroid gland diseases 
is higher among women aged over 60 years, which is 
shown by a more frequent occurrence of antithyroid 
antibodies at this age [41]. According to the studies, it 
cannot be excluded that the autoimmune phenomena 
taking place in the thyroid gland, irrespective of their 
effect on the thyroid gland function, may play a direct 
role in the impairment of the cognitive status observed 
in the older population with sub-clinical hypothyroid-
ism [42].
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In our own study, a significant negative effect of 
anti-TPO was observed in the results for memory, verbal 
memory, and psychomotor speed. The concentration of 
anti-Tg positively correlated with the results for reac-
tion time. In turn, the level of antibodies against TSH 
receptor was negatively related with the results of NCI, 
executive functions, and cognitive flexibility.
In a previously quoted study by Grigorova et al., 
and similar to our own study, the level of anti-thyroid 
antibodies on cognitive functions was evaluated. It 
was observed that higher concentrations of anti-thy-
roglobulin antibodies positively correlated with a larger 
number of mistakes in the Trial Making Test Part B, in 
the Word Fluency test, and in the Design Fluency test. 
The researchers suggest that a higher concentration of 
TgAB, but within normal values, may exert a negative 
effect on executive functions, which was not confirmed 
in our own study [43]. Many other studies confirm the 
negative effect of high titres of anti-thyroglobulin and 
anti-thyroid peroxidase antibodies on the results of 
cognitive functions [44, 45].
Despite the above-presented reports, Regal men-
tioned that after the correction of data for multiple 
comparisons in the analysis of variance, no correlations 
were observed between titres of anti-thyroglobulin 
and anti-thyroid peroxidase antibodies in the analysed 
cognitive tests [46].
In the context of the presented study, the study 
conducted among patients with hyperthyroidism in the 
course of Graves-Basedow disease is interesting. Impor-
tant disorders are presented with respect to operative 
memory and executive functions related with the func-
tion of the prefrontal cortex of the brain, compared to 
healthy individuals [47]. This could be consistent with 
the results obtained in the presented study, provided 
that the majority of persons with Graves-Basedow 
disease had increased titres of AB-TSHR antibodies, 
because in this study it was found that the concentra-
tion of antibodies against TSH receptor negatively 
correlated with the results of NCI, executive functions, 
and cognitive flexibility.
Conclusions
The developed models of cognitive functions show 
a considerable effect of TSH, fT4, AB-TSHR, and anti-
TPO, as well as TT4 and anti-Tg, on the level of cognitive 
functions after menopause in the examined group. This 
suggests the need for studies on the functional state of 
the thyroid gland in postmenopausal women showing 
cognitive functions disorders.
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